The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...

The Big Three handle at least 80% of the country’s insulin prescriptions. The price of insulin has exponentially increased in ...

The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's ...

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...

List prices are what a drugmaker initially sets for a product and what people who have no insurance or plans with high ...